Germany Viscosupplementation Market Size & Outlook
Germany viscosupplementation market, 2018-2030 (US$M)
Related Markets
Germany viscosupplementation market highlights
- The Germany viscosupplementation market generated a revenue of USD 119.1 million in 2023 and is expected to reach USD 240.1 million by 2030.
- The Germany market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
- In terms of segment, three injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 119.1 million |
| Market revenue in 2030 | USD 240.1 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Three injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Germany accounted for 2.5% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, France viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 270.0 million by 2030.
Three injection was the largest segment with a revenue share of 42.99% in 2023. Horizon Databook has segmented the Germany viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
Osteoarthritis is the most common joint disease in Germany as well globally. In 2017, Journal of Health Monitoring published the findings of the interview survey conducted by GEDA 2014/2015-EHIS in Germany. Women in the 45 to 64 and over-65 age groups are affected significantly more frequently by osteoarthritis than men.
Companies like Anika Therapeutics and Fidia Pharmaceutica S.p.A are the key distributor in the region. OPTIVISC is a synthetic HA marketed by Ivy Sports Medicine, Germany, for treatment of OA, improve joint mobility and reduce pain sensitivity for up to 6 months.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany viscosupplementation market size, by product, 2018-2030 (US$M)
Germany Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
